These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37574254)

  • 1. Impaired skeletal muscle health in Parkinsonian syndromes: clinical implications, mechanisms and potential treatments.
    Murphy KT; Lynch GS
    J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1987-2002. PubMed ID: 37574254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-of-illness in multiple system atrophy and progressive supranuclear palsy.
    Winter Y; Stamelou M; Cabanel N; Sixel-Döring F; Eggert K; Höglinger GU; Herting B; Klockgether T; Reichmann H; Oertel WH; Dodel R; Spottke AE
    J Neurol; 2011 Oct; 258(10):1827-34. PubMed ID: 21479850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
    Archer DB; Bricker JT; Chu WT; Burciu RG; McCracken JL; Lai S; Coombes SA; Fang R; Barmpoutis A; Corcos DM; Kurani AS; Mitchell T; Black ML; Herschel E; Simuni T; Parrish TB; Comella C; Xie T; Seppi K; Bohnen NI; Müller ML; Albin RL; Krismer F; Du G; Lewis MM; Huang X; Li H; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Lancet Digit Health; 2019 Sep; 1(5):e222-e231. PubMed ID: 33323270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower urinary tract dysfunction in Parkinsonian syndromes.
    Vichayanrat E; Hentzen C; Batla A; Simeoni S; Iodice V; Panicker JN
    Neurol Sci; 2021 Oct; 42(10):4045-4054. PubMed ID: 34318363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA and circRNA in Parkinson's Disease and atypical parkinsonian syndromes.
    Bougea A; Stefanis L
    Adv Clin Chem; 2023; 115():83-133. PubMed ID: 37673523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson's disease and atypical Parkinsonian syndromes.
    Schröter N; van Eimeren T; Classen J; Levin J; Redecker C; Wolz M; Tönges L
    J Neural Transm (Vienna); 2023 Jun; 130(6):839-846. PubMed ID: 37046147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative care and its emerging role in Multiple System Atrophy and Progressive Supranuclear Palsy.
    Wiblin L; Lee M; Burn D
    Parkinsonism Relat Disord; 2017 Jan; 34():7-14. PubMed ID: 28341224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
    Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
    Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtle Esophageal Motility Alterations in Parkinsonian Syndromes: Synucleinopathies vs. Tauopathies.
    Claus I; Suttrup J; Muhle P; Suntrup-Krueger S; Siemer ML; Lenze F; Dziewas R; Warnecke T
    Mov Disord Clin Pract; 2018; 5(4):406-412. PubMed ID: 30363410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.
    Miki Y; Foti SC; Asi YT; Tsushima E; Quinn N; Ling H; Holton JL
    Brain; 2019 Sep; 142(9):2813-2827. PubMed ID: 31289815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical parkinsonian syndromes: a general neurologist's perspective.
    Deutschländer AB; Ross OA; Dickson DW; Wszolek ZK
    Eur J Neurol; 2018 Jan; 25(1):41-58. PubMed ID: 28803444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A disease-specific metabolic brain network associated with corticobasal degeneration.
    Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
    Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
    Tupe-Waghmare P; Rajan A; Prasad S; Saini J; Pal PK; Ingalhalikar M
    Eur Radiol; 2021 Nov; 31(11):8218-8227. PubMed ID: 33945022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical findings: Atypical parkinsonian syndromes or Atypical parkinsonian syndromes look-alikes.
    Calikusu FZ; Akkus S; Kochan Kizilkilic E; Poyraz BC; Altunç AT; Kiziltan G; Gunduz A
    Clin Neurol Neurosurg; 2023 Oct; 233():107975. PubMed ID: 37734268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
    Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
    Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
    Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.
    Saeed U; Compagnone J; Aviv RI; Strafella AP; Black SE; Lang AE; Masellis M
    Transl Neurodegener; 2017; 6():8. PubMed ID: 28360997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.